Abstract Background Neuroendocrine tumors (NETs) are a heterogeneous group of tumors,
with> 50% of cases involving the gastrointestinal system or pancreas. Somatostatin analogs …

Neuroendocrine neoplasms (NENs) are a heterogeneous group of rare tumors with different
types of physiology and prognosis. Therefore, prognostic information, including …

BACKGROUND Currently, several indole markers are measured separately to support
diagnosis and follow-up of patients with neuroendocrine tumors (NETs). We have developed …

Simple Summary Pancreatic neuroendocrine tumors are composite entities due to their
heterogeneity illustrated in clinical behavior, mutational pattern, and site of origin. Pancreatic …

Background Intrapancreatic accessory spleen (IPAS) is an uncommon finding of pancreatic
mass. Differential diagnosis with pancreatic tumor, especially with non-functional …

Small intestinal neuroendocrine tumors (SI-NETs) are amine-and peptide-producing
neoplasms. Most patients display metastases at the time of diagnosis; they have an …

Pancreatic neuroendocrine neoplasms (panNENs) are rare pancreatic neoplasms, and
descriptions of treatment remain limited. Autotaxin (ATX) is a secreted autocrine motility …

Abstract Purpose of Review Classification and nomenclature of neuroendocrine neoplasms
(NEN) have frequently changed over the last years. These changes reflect both increasing …

Biochemical Markers for Neuroendocrine Tumors: Traditional Circulating Markers and Recent
Development—A Comprehensive Review Page 1 Diagnostics 2024, 14, 1289. https://doi.org/10.3390/diagnostics14121289 …

Abstract Background Urinary 5‐hydroxyindoleacetic acid (5‐HIAA) is an established
biomarker in neuroendocrine tumors and carcinoid syndrome; however, its role in …